Home » Smallpox monkeys: Gismondo, not serious but therapies are lacking – Healthcare

Smallpox monkeys: Gismondo, not serious but therapies are lacking – Healthcare

by admin
Smallpox monkeys: Gismondo, not serious but therapies are lacking – Healthcare

After the isolation of the virus “we can proceed with the research on new antiviral molecules”, even if the monkeypox remains a disease “not serious, which does not threaten lethality except in very rare cases of fragile or immunocompromised people. they are targeted therapies “. Maria Rita Gismondo, the director of the laboratory of clinical microbiology, virology and bio-emergency diagnostics of the Sacco hospital in Milan, told ANSA that yesterday she isolated the ‘monkeypoxvirus’, responsible for monkeypox currently present in Europe.

The symptoms, added Gismondo, “are headache, sore pustules. Someone had a high fever one or two days, others not”. But at the moment, even if “some antivirals have shown good activity, there is no molecule directed against this virus. Now we can test new ones that may be effective in preventing infection”. In any case, “we are not talking about the picture we remember of the human smallpox virus”, it is often “a few pustules on the back, limbs or face that dry up and heal within a week”.

Smallpox monkeys: Gismondo (Sacco), vaccine campaign not justified
‘At the most targeted administrations to health-laboratories’
Against monkeypox “I don’t even think it can be called a vaccination campaign”, at most we can talk about “targeted” administration, for example, to personnel “who have had an accident in the laboratory or during the treatment of a patient. But neither the number of cases nor the type of disease justifies a vaccination campaign “. Maria Rita Gismondo, the director of the laboratory of clinical microbiology, virology and bio-emergency diagnostics of the Sacco hospital in Milan, told ANSA that yesterday she isolated the ‘monkeypoxvirus’, responsible for monkeypox currently present in Europe.

See also  Covid: life-saving pre-intervention vaccine in cancer patients

“What we have traced – he added – refers either to subjects who participated in an event in the Canaries or to residents in European countries who, upon returning from the Canaries, had close contacts with these people, especially of a sexual nature”. Now, therefore, “if we are able to inform subjects at risk and people who have had close contacts well – she concluded – we can certainly limit” the situation.

breaking latest news © Copyright ANSA

<![CDATA[]]>

<![CDATA[]]>


This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy